Ronald Brus resigns from the Galapagos Board
(Thomson Reuters ONE) -
Mechelen, Belgium; 30 May 2011 - Galapagos NV (Euronext: GLPG) announced today
that Dr Ronald Brus has resigned from the Board of Directors.
Ronald Brus is President and Chief Executive Officer of Crucell. Dr Brus was a
member of the Galapagos Board of Directors from 2000 until Galapagos' IPO in May
2005 and later rejoined the Board in April 2010. In February 2011, Crucell was
acquired by Johnson & Johnson. Corporate policies at Johnson & Johnson
stipulate that managers cannot serve as a member of any Board of Directors, and
therefore Dr Brus resigned from Galapagos' Board effective 25 May 2011.
"We thank Ronald again for his contribution as a Board member," said Onno van de
Stolpe, CEO of Galapagos. "Ronald has been involved with Galapagos from the
start, and we have benefited from his strategic insights and experience as a
successful biotech CEO. We wish him the best within Johnson & Johnson."
About Galapagos
Galapagos (Euronext: GLPG; OTC: GLPYY) is a mid-size biotechnology company
specialized in the discovery and development of small molecule and antibody
therapies with novel modes-of-action. The Company is progressing one of the
largest pipelines in biotech, with six programs in development and over 50
discovery programs. Through risk/reward-sharing alliances with GlaxoSmithKline,
Lilly, Janssen Pharmaceutica, Roche and Servier, Galapagos is eligible to
receive up to ?2.5 billion in downstream milestones, plus royalties. The
Galapagos Group has over 800 employees and operates facilities in seven
countries, with global headquarters in Mechelen, Belgium. More info at:
www.glpg.com
CONTACT
Galapagos NV
Elizabeth Goodwin, Director Investor Relations
Tel: +31 6 2291 6240
ir(at)glpg.com
This release may contain forward-looking statements, including, without
limitation, statements containing the words "believes," "anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will," "could,"
"stands to," and "continues," as well as similar expressions. Such forward-
looking statements may involve known and unknown risks, uncertainties and other
factors which might cause the actual results, financial condition, performance
or achievements of Galapagos, or industry results, to be materially different
from any historic or future results, financial conditions, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, the reader is advised not to place any undue reliance on
such forward-looking statements. These forward-looking statements speak only as
of the date of publication of this document. Galapagos expressly disclaims any
obligation to update any such forward-looking statements in this document to
reflect any change in its expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based, unless
required by law or regulation.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE
[HUG#1519847]
Unternehmensinformation / Kurzprofil:
Datum: 30.05.2011 - 18:00 Uhr
Sprache: Deutsch
News-ID 55122
Anzahl Zeichen: 3831
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 304 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ronald Brus resigns from the Galapagos Board"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
